Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2021 September Clinical practice Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed and relapsed/... Read more
2021 September Clinical trials Ixazomib, daratumumab and low-dose dexamethasone in frail patients with newly diagnosed multip... Read more
2021 September Science Genetic identification of older AML patients achieving long-term survival with intensive chemo... Read more
2021 September Prevention Impaired responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–direct... Read more
2021 September Clinical trials Early, deep and durable responses with ciltacabtagene autoleucel in multiple myeloma Read more
2021 June Editor's pick RELEVANT LITERATURE FOR YOUR DAILY PRACTICE SELECTED BY: JAN VAN DROOGENBROECK Read more
Top
